SEMBACH, Germany — Today’s battlefield looks much different than the battlefields of yesteryear with the advancement of autonomous drone technology and AI-enabled or assisted targeting processes, battlefield medicine also is advancing its technology.
U.S. Army medical leaders in Europe are fielding a new handheld diagnostic tool that can identify traumatic brain injuries in as little as 15 minutes. The i-STAT Alinity uses a small blood sample to detect biomarkers released after a brain injury occurs.
“This is probably the single most important advancement in traumatic brain injury care in the last 15 to 20 years,” said Lt. Col. Bradley A. Dengler, the neurosurgery consultant to the Army Surgeon General and director of the Military Traumatic Brain Injury Initiative at the Uniformed Services University. “Historically, we’ve missed a lot of these injuries.”
Unlike traditional concussion evaluations that are subjective questioning, the new system gives medics an objective way to determine whether a Soldier has suffered neural damage. For Soldiers operating in remote environments, that speed and accuracy can mean the difference between returning safely to duty, receiving immediate treatment, or avoiding a potentially life-threatening delay in care.
The system is currently being integrated into forward units under 10th Army Air and Missile Defense Command. Air defense formations are highly dispersed, frequently operating in austere locations hours away from advanced medical facilities and computed tomography, or CT, scanners.
For Col. Jessica Peck, the command surgeon for 10th AAMDC, the technology addresses an urgent operational vulnerability.
“In Central Command, we’re seeing disproportionately high traumatic brain injury rates in air defense,” said Peck. “These jobs demand extremely high cognitive performance. Even a mild traumatic brain injury can significantly degrade effectiveness, impacting coordination, emotional regulation, spatial awareness, and decision-making.” The handheld device functions by measuring two brain-specific proteins that leak through the blood-brain barrier following trauma. The first is glial fibrillary acidic protein, which originates from astrocytes, rises slowly, and remains elevated for five to seven days. The second is ubiquitin carboxyl-terminal hydrolase L1, which originates from neurons, spikes quickly, and clears rapidly.
Medics draw blood, place a drop onto a testing cartridge, and insert it into the analyzer. If the proteins are elevated, brain injury is confirmed, even if a standard CT scan misses it.
According to Dengler, certain GFAP levels can correspond to a normal CT scan but show clear, abnormal damage to a magnetic resonance imaging scan. Conversely, if the biomarkers are not elevated, there is a 99% chance that there is no bleeding in the brain.
For years, medics relied primarily on the Military Acute Concussion Evaluation, a 15-minute standardized cognitive assessment involving memory lists and concentration exercises. While widely used, the process is labor-intensive and easily manipulated.
“People can intentionally perform better or worse depending on what they want the outcome to be,” Peck said. “A lot of special operations personnel have memorized the word lists, so they can essentially ‘beat’ the test.” Furthermore, if a medic is overwhelmed during a mass casualty or has an unresponsive patient, subjective testing quality naturally degrades or isn’t possible. The handheld test removes human error from the equation because patients cannot fake a blood test.
The numbers also provide a biological map of injury severity. A critical protein score indicates a patient requires emergency brain surgery, while a low elevation indicates a day or two of rest and returning to work. In a chaotic triage environment filled with unresponsive, intubated patients, a medic can test the blood of all of them and instantly prioritize who takes the first medical evacuation seat.
In large-scale combat operations, losing combat power to unnecessary evacuations is unsustainable. Over 20 years of conflict in Iraq and Afghanistan, about 68 percent of people evacuated for head CT scans from frontline positions were ultimately returned to duty. Each evacuee was sent to the closest CT scanner for evaluation, which is Landstuhl Regional Medical Center in Germany. This is a major cost in transportation as well.
The Army has already operationally assessed the system during deployments in the Middle East. According to Dengler, utilizing biomarkers prevented roughly 13 tactical medical evacuations across Central Command between 2021 and 2022 by providing definitive reassurance to remote medical providers. For air defense formations, the crews operate specialized equipment in small, tightly coordinated teams, keeping these Soldiers forward is critical.
Peck said that taking even one person out of a crew affects the entire team because these are highly specialized roles.
Because the cartridges require refrigeration, they cannot be kept in every individual tactical vehicle, but they will be maintained at established Role 1 frontline care sites. This allows forward medics, who are integrated with the unit, to pull an objective metric and immediately consult remote neurosurgery experts, effectively pushing elite medical expertise directly to the front lines.
Beyond battlefield readiness, this technology also addresses long-term health implications. Failing to identify a mild traumatic brain injury increases the risk of a Soldier returning to duty too early, where a secondary head injury can cause catastrophic injuries.
Dengler said, one of the greatest challenges is the warrior culture itself. He emphasized that Soldiers are incredibly driven and will keep pushing through to stay in the fight, often failing to recognize how cognitively impaired they are after an injury.
The new test represents a historic milestone as one of the first major Army-funded research efforts to start at the Walter Reed Army Institute of Research, advance through clinical trials, achieve Food and Drug Administration approval, and successfully deploy to operational combat units.
According to Dengler, while currently fielded to detect acute brain injuries up to 24 hours after injury, the system's cartridge-dependent platform can also run standard blood chemistries. Civilian trauma centers, including the University of California, San Francisco, are already using it to streamline emergency room throughput. Future military and civilian applications are expected to expand into stroke detection and tracking responses to clinical therapies.
As modern warfare increasingly places Soldiers in fast-moving, high-risk environments, objective diagnostic tools like the i-STAT will become non-negotiable components of battlefield medicine.
“This helps us take better care of Soldiers,” Peck said. “It helps us identify injuries faster, guide recovery better, and ultimately return people safely to the fight when they’re ready.”